Checked.be
Active
BE 0794.448.212Private limited company
K.Slk
Paul Devignestraat 101 ·1030 Schaarbeek, Belgium· 3 yrs active
Sector: Dental practice
(86230)
Conclusion
K.Slk has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €99k and a net result of €64k. Equity is growing by ~14.7% per year across the filed fiscal years. Its solvency ranks better than 27% of 16132 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Based on the State Gazette, CBE and 4 annual accounts.
Key figures
| Equity | €99k |
| Net result | €64k |
| Better than sector | 27% |
| Active | 3 yrs |
Financial profile
72
/ 100
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Health
75
Profitability
100
Solvency
60
Growth
32
Stability
94
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
75
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€7k
estimate, not credit advice
Score history
85
2022
93
2023
93
2024
75
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 1.46 (≥ 1.0)
+5
Quick ratio
Quick ratio 1.46 (≥ 1.0)
+5
Profitability
ROE 65% (≥ 10%)
+10
Interest coverage
Interest coverage 296.4× (≥ 3×)
+8
Profit trend
Net profit down YoY
-3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 29-07-2026 with the NBB · fiscal year 2025 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~14.7%/year over 4 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 31.7% | 63.4% | |
| Net result | €64k | €62k | |
| Equity | €99k | €132k | |
| Gross operating margin | €89k | €116k | |
| Total assets | €312k | €286k |
€88k
-20.0%
22-25
€64k
-18.5%
22-25
€71k
-20.0%
22-25
€312k
-20.2%
22-25
€99k
-70.5%
22-25
€99k
-69.9%
22-25
€17k
-21.4%
22-25
€300k
-
22-25
€213k
+280.6%
22-25
€213k
+285.0%
22-25
1.46
-78.9%
22-25
1.46
-78.9%
22-25
31.7%
-63.0%
22-25
2.15
+1189.5%
22-25
64.7%
+176.2%
22-25
20.5%
+2.2%
22-25
296.44
-77.4%
22-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - |
| EBITDA | €88k | €110k | €143k | €199k |
| Net profit | €64k | €78k | €103k | €151k |
| Cash flow | €71k | €88k | €113k | €154k |
| Staff costs | - | - | - | - |
| Income taxes | €17k | €22k | €30k | €45k |
| Dividends | €300k | - | - | - |
| Total assets | €312k | €391k | €338k | €211k |
| Equity | €99k | €335k | €256k | €154k |
| Debt | €213k | €56k | €82k | €58k |
| of which ≤ 1y | €213k | €55k | €82k | €57k |
| of which > 1y | - | - | - | - |
| Working capital | €99k | €329k | €240k | €127k |
| Employees (FTE) | - | - | - | - |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Current ratio | 1.46 | 6.95 | 3.94 | 3.22 |
| Quick ratio | 1.46 | 6.95 | 3.94 | 3.22 |
| Working capital ratio | 31.7% | 84.1% | 70.9% | 60.2% |
| Solvency | 31.7% | 85.7% | 75.7% | 72.7% |
| Debt / equity | 2.15 | 0.17 | 0.32 | 0.38 |
| Long-term debt ratio | - | - | - | - |
| Interest coverage | 296.44 | 1310.36 | 3458.02 | - |
| Gross margin | - | - | - | - |
| Net margin | - | - | - | - |
| ROA | 20.5% | 20.1% | 30.4% | 71.3% |
| ROE | 64.7% | 23.4% | 40.1% | 98.0% |
| EBITDA margin | - | - | - | - |
| Days sales outstanding | - | - | - | - |
| Days payable outstanding | - | - | - | - |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (22 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €312k | €391k | €338k | €211k |
| Fixed assets | 21/28 | - | €7k | €17k | €27k |
| Tangible fixed assets | 22/27 | - | €7k | €17k | €27k |
| Current assets | 29/58 | €312k | €384k | €322k | €184k |
| Amounts receivable within one year | 40/41 | €3k | - | €22k | - |
| Investments | 50/53 | €150k | - | - | - |
| Cash & bank | 54/58 | €149k | €294k | €109k | - |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €312k | €391k | €338k | €211k |
| Equity | 10/15 | €99k | €335k | €256k | €154k |
| Contributions / capital | 10/11 | €3k | €3k | €3k | €3k |
| Accumulated profits (losses) | 14 | €96k | €332k | €253k | €151k |
| Amounts payable | 17/49 | €213k | €56k | €82k | €58k |
| Amounts payable within one year | 42/48 | €213k | €55k | €82k | €57k |
| Trade debts payable within one year | 44 | - | €545 | €4k | €545 |
| Income statement | |||||
| Gross operating margin | 9900 | €89k | €111k | €143k | €200k |
| Operating result | 9901 | €82k | €100k | €133k | €195k |
| Financial income | 75 | €0 | - | - | - |
| Financial charges | 65 | €298 | €84 | €41 | - |
| Result before taxes | 9903 | €81k | €100k | €133k | €195k |
| Income taxes | 67/77 | €17k | €22k | €30k | €45k |
| Net result for the period | 9904 | €64k | €78k | €103k | €151k |
| Result to be appropriated | 9905 | €64k | €78k | €103k | €151k |
Legal Structure
| NACE primary | Dental practice(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 06-12-2022 |
| Status | Active |
| Postal code | 1030 |
Establishment units
-
since 20222.342.728.558
Real-estate footprint
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21904B0460/00S002 | Brussels | 183 m² | 1 · 92 m² | 16.9 m · 5 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
29-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €64k ▼18.5%
Net result drops to €64k, the lowest in the series.
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Equity above €200kEq €256k ▲66.9%
2 profitable years in a row build equity to €256k.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Dental practice86230
Names & trade names
| Legal nameFR | K.Slk |
Similar companies
K.R.S.M.
BE 0507.629.704 · Sint-Genesius-Rode
DR BRANS DENTAL
BE 1003.334.841 · Esneux
BUILDING SMILES
BE 0792.372.313 · Ukkel
DONYDENTAL
BE 1005.858.821 · Olne
DENTAL CARE +
BE 0700.360.091 · Schaarbeek